29.14
前日終値:
$29.18
開ける:
$29.14
24時間の取引高:
212.50K
Relative Volume:
0.56
時価総額:
$936.56M
収益:
$566.77M
当期純損益:
$48.16M
株価収益率:
24.49
EPS:
1.19
ネットキャッシュフロー:
$274.29M
1週間 パフォーマンス:
+0.97%
1か月 パフォーマンス:
+5.58%
6か月 パフォーマンス:
-4.46%
1年 パフォーマンス:
-10.14%
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
名前
Collegium Pharmaceutical Inc
セクター
電話
781-713-3699
住所
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
COLL
Collegium Pharmaceutical Inc
|
29.14 | 927.62M | 566.77M | 48.16M | 274.29M | 1.19 |
![]()
HLN
Haleon Plc Adr
|
11.35 | 50.14B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
ZTS
Zoetis Inc
|
168.63 | 72.38B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
RDHL
Redhill Biopharma Ltd Adr
|
1.79 | 4.22M | 35.75M | 11.57M | -26.25M | -3.8069 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 45.51B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.45B | 16.54B | -1.64B | 749.00M | -1.45 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-10 | アップグレード | Needham | Hold → Buy |
2024-07-30 | アップグレード | H.C. Wainwright | Neutral → Buy |
2024-06-07 | アップグレード | Jefferies | Hold → Buy |
2024-05-10 | ダウングレード | Needham | Buy → Hold |
2024-05-10 | ダウングレード | Piper Sandler | Overweight → Neutral |
2024-01-04 | ダウングレード | Jefferies | Buy → Hold |
2023-08-25 | 繰り返されました | Needham | Buy |
2023-05-02 | 再開されました | Jefferies | Buy |
2022-08-08 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2022-02-15 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
2021-08-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2021-01-11 | 繰り返されました | H.C. Wainwright | Buy |
2020-07-14 | 開始されました | BWS Financial | Sell |
2020-05-27 | 開始されました | Guggenheim | Neutral |
2020-02-19 | 再開されました | Jefferies | Buy |
2019-10-30 | 繰り返されました | Needham | Buy |
2019-05-03 | 再開されました | H.C. Wainwright | Buy |
2019-04-12 | 再開されました | Janney | Buy |
2019-03-20 | 開始されました | SunTrust | Hold |
2019-01-16 | 繰り返されました | Needham | Buy |
2018-03-08 | 繰り返されました | H.C. Wainwright | Buy |
2018-02-07 | 繰り返されました | Needham | Buy |
2017-12-05 | 繰り返されました | Needham | Buy |
2017-09-11 | 開始されました | H.C. Wainwright | Buy |
2017-05-11 | 繰り返されました | Needham | Buy |
2016-09-13 | 開始されました | Gabelli & Co | Buy |
2015-06-01 | 開始されました | Jefferies | Buy |
2015-06-01 | 開始されました | Needham | Buy |
2015-06-01 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Collegium Pharmaceutical Inc (COLL) 最新ニュース
ProShare Advisors LLC Increases Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Millennium Management LLC Raises Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ameriprise Financial Inc. - Defense World
Deutsche Bank AG Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Jane Street Group LLC Sells 20,543 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.80 - Defense World
Collegium Pharmaceutical's (NASDAQ:COLL) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
Collegium Pharmaceutical Approves 2025 Equity Incentive Plan - TipRanks
Collegium Pharmaceutical, Inc. to Present at Mizuho Neuro & Ophthalmology Summit and Jefferies Global Healthcare Conference - Nasdaq
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical to Present at Mizuho Neuro Summit and Jefferies Healthcare Conference - Stock Titan
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Comerica Bank - Defense World
There May Be Reason For Hope In Collegium Pharmaceutical's (NASDAQ:COLL) Disappointing Earnings - simplywall.st
Voya Investment Management LLC Sells 789 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical (COLL) Initiates $25 Million Share Repu - GuruFocus
Collegium Pharmaceutical buys back $25 million in shares By Investing.com - Investing.com Canada
Collegium Pharmaceutical initiates $25M share buyback By Investing.com - Investing.com Canada
Collegium Pharmaceutical Signs $25 Million Accelerated Share Buyback Deal With Jefferies - marketscreener.com
Collegium Announces $25 Million Accelerated Share Repurchase Program - marketscreener.com
Collegium Pharmaceutical initiates $25M share buyback - Investing.com
Collegium Pharmaceutical enters into accelerated share repurchase agreement - MSN
Collegium Pharmaceutical Announces Share Repurchase Agreement - TipRanks
Collegium Pharmaceutical buys back $25 million in shares - Investing.com Australia
Collegium Pharmaceutical Announces $25 Million Accelerated Share Repurchase Agreement with Jefferies LLC - Nasdaq
Collegium pharmaceutical targets $135M in Jornay PM revenue for 2025 amid sales force expansion - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap Up – Time to Buy? - Defense World
(COLL) Proactive Strategies - news.stocktradersdaily.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q1 2025 Earnings Call Transcript - Insider Monkey
Collegium Pharmaceutical (COLL) Sees Price Target Increase by Pi - GuruFocus
COLL Reaffirms FY25 Adjusted EBITDA Outlook and Highlights Strat - GuruFocus
Collegium Pharmaceutical’s Earnings Call Highlights Growth and Strategic Initiatives - TipRanks
Collegium Pharmaceutical (COLL) Price Target Increased by Piper Sandler | COLL Stock News - GuruFocus
Earnings call transcript: Collegium Pharmaceutical sees strong Q1 2025 growth - Investing.com India
Pacer Advisors, Inc. Reduces Stake in Collegium Pharmaceutical I - GuruFocus
Collegium Pharmaceutical Q1 2025 Earnings Call Transcript - MarketBeat
Collegium Pharmaceutical Inc (COLL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada
Collegium Pharmaceutical Reports Strong Q1 2025 Growth - TipRanks
Collegium Pharmaceutical: Q1 Earnings Snapshot - New Haven Register
Collegium Pharmaceutical, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:COLL) - Seeking Alpha
Pacer Advisors, Inc. Significantly Reduces Holdings in Collegium Pharmaceutical Inc. - GuruFocus
Pacer Advisors, Inc. Reduces Stake in Collegium Pharmaceutical Inc - GuruFocus
Collegium Pharmaceutical (NASDAQ:COLL) Exceeds Q1 Expectations - Yahoo Finance
Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Collegium Pharmaceutical Reports 23% Revenue Increase - TipRanks
Collegium Pharmaceutical Inc (COLL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):